Drug-free Capsules for Diabetes Prevention and Weight Loss
Epitomee medical is a public company developing and commercializing ingestible therapeutic devices, aimed to tackle some of today’s most prevalent chronic diseases with a self-managed, safer, kinder to the system and more manageable way.
Epitomee’s groundbreaking platform technology is based on self-expanding hydro-gel scaffolds folded into a standard pharmaceutical capsule, produced from biocompatible excipients, food additives, and food contact materials. Epitomee’s hydro-gel scaffolds can be engineered to be triggered by different zone-specific pH levels, allowing the allocation of an indication-specific deployment region for every product to enable an optimal therapeutic effect.
| Name | Epitomee Medical |
|---|---|
| Slug | tulip-medical |
| Former names | Tulip Medical |
| Type / kind | startup |
| Crunchbase ID | epitomee-medical |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgLOe4JkIDA |
| Status | active |
|---|---|
| Status reason | Public on TASE on Dec, 2021; |
| Last update | 2026-05-17 |
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Caesarea |
| HQ address | Tarshish Industrial Park Street 19, Caesarea, Israel |
| Website | https://epitomeemedical.com |
|---|---|
| https://www.linkedin.com/company/28622557 | |
| YouTube | https://www.youtube.com/channel/UCoHh9O_psVRM4nPUv9SVwsg |
| Total raised | $77.0M |
|---|---|
| Current stage | Public |
| Market cap | $57.0M |
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}